A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer

Full Title

STUDY OF DOSE DENSE CMF (cyclophosphamide, methotrexate, fluorouracil) as an alternative to AC (doxorubicin, cyclophosphamide) in 2 regimens in EARLY STAGE BREAST CANCER for patients greater or equal to 70

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Pamela Drullinsky’s office at 212-987-1777.

Protocol
26-303
Phase
Phase II (phase 2)
Disease Status
Newly Diagnosed
Investigator
Pamela R. Drullinsky
Co-Investigators
Koshy Alexander
Jasmeet C. Singh
Diseases
Breast Cancer
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07768436
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description